Dietary vitamin D supplementation attenuates immune responses of pigs challenged with rotavirus potentially through the retinoic acid-inducible gene I signalling pathway. Issue 3 (14th August 2014)

• Record Type: Journal Article
• Authors: Zhao, Ye; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping; Yu, Jie; Han, Guoquan; Liang, Xiaofang; Chen, Daiwen
• Is Part Of: British journal of nutrition. Volume 112:Issue 3(2014)
• Page Start: 381
• Page End: 389
• Publication Date: 2014-08-14
• Subjects: Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S000711451400097X
• Languages: English
• ISSNs: 0007-1145

Abstract

<abstract abstract-type="normal"> <title> <x content-type="archive" xml:space="preserve">Abstract</x> </title> <p>In the present study, twenty-four Duroc × Landrance × Yorkshire (initial body weight (BW) of 21·82 (<sc>sem</sc> 2·06) kg) cross-bred pigs were used to determine whether dietary vitamin D supplementation could confer protection against viral infections through the retinoic acid-inducible gene I (RIG-I) signalling pathway in pigs. Experimental treatments were arranged in a 2 × 2 factorial manner with the main effects of immune challenge (control <italic>v.</italic> porcine rotavirus (PRV) challenge) and dietary concentrations of vitamin D (200 and 5000 IU; where 1 IU of vitamin D is defined as the biological activity of 0.025 mg of cholecalciferol). The pigs were fed a diet containing 200 or 5000 IU vitamin D in the first week of the study period. On day 8, the pigs were orally dosed with 4 ml of Dulbecco's modified Eagle's medium/Ham's F-12 medium containing PRV or essential medium (control). Serum samples were collected on day 8 (pre-challenge), and 6 d after the PRV challenge, the pigs were killed to evaluate intestinal morphology and tissue gene expression following the last blood collection. Pigs challenged with PRV had decreased BW gain (<italic>P</italic>< 0·01), feed intake (<italic>P</italic>< 0·01), villus height (<italic>P</italic>< 0·01), faecal consistency (<italic>P</italic>< 0·05), and serum 1, 25-dihydroxyvitamin D concentration (<italic>P</italic>< 0·01) and increased (<italic>P</italic>< 0·01) serum IL-2, IL-6 and interferon (IFN)-β concentrations. Vitamin D supplementation mitigated these effects. The mRNA expression of <italic>RIG-I</italic> (<italic>P</italic>< 0·01), IFN-β promoter stimulator 1 (<italic>P</italic>< 0·01), <italic>IFN-β</italic> (<italic>P</italic>< 0·01) and interferon-stimulated gene 15 (<italic>ISG</italic><sub><italic>15</italic></sub>) (<italic>P</italic>< 0·01) was up-regulated by the PRV challenge and vitamin D supplementation in the intestine. In conclusion, vitamin D supplementation could activate the RIG-I signalling pathway and thus alleviate the negative effects caused by PRV challenge.</p> </abstract>